Upgrade to SI Premium - Free Trial

Medline Inc (MDLN) PT Lowered to $45 at Stifel

August 6, 2026 8:10 AM
Stifel analyst Rick Wise lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $50.00) while maintaining a Buy rating.

Categories

Analyst PT Change